- Home
- BON vs ATNF Comparison
BON vs ATNF Comparison
Compare BON & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BON
- ATNF
- Stock Information
- Founded
- BON 2006
- ATNF 2016
- Country
- BON China
- ATNF United States
- Employees
- BON N/A
- ATNF N/A
- Industry
- BON Medicinal Chemicals and Botanical Products
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- BON Health Care
- ATNF Health Care
- Exchange
- BON Nasdaq
- ATNF Nasdaq
- Market Cap
- BON 6.6M
- ATNF 5.7M
- IPO Year
- BON 2021
- ATNF N/A
- Fundamental
- Price
- BON $1.42
- ATNF $1.44
- Analyst Decision
- BON
- ATNF
- Analyst Count
- BON 0
- ATNF 0
- Target Price
- BON N/A
- ATNF N/A
- AVG Volume (30 Days)
- BON 36.1K
- ATNF 1.1M
- Earning Date
- BON 02-07-2025
- ATNF 02-13-2025
- Dividend Yield
- BON N/A
- ATNF N/A
- EPS Growth
- BON N/A
- ATNF N/A
- EPS
- BON 2.22
- ATNF N/A
- Revenue
- BON $25,555,939.00
- ATNF N/A
- Revenue This Year
- BON $47.04
- ATNF N/A
- Revenue Next Year
- BON $77.63
- ATNF $54.15
- P/E Ratio
- BON $0.63
- ATNF N/A
- Revenue Growth
- BON N/A
- ATNF N/A
- 52 Week Low
- BON $1.23
- ATNF $1.16
- 52 Week High
- BON $6.00
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- BON 42.33
- ATNF 39.69
- Support Level
- BON $1.30
- ATNF $1.43
- Resistance Level
- BON $1.70
- ATNF $1.67
- Average True Range (ATR)
- BON 0.13
- ATNF 0.13
- MACD
- BON -0.04
- ATNF 0.00
- Stochastic Oscillator
- BON 32.13
- ATNF 21.82
About BON Bon Natural Life Limited
Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from perfumes and fragrance products.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.